Dalil Hamroun

7PUBLICATIONS
37CO-AUTHORS
Animal growth and developmentTime-series analysisMajor global burdens of diseasePredictive and prognostic markersDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 16, 2026
Real-Life Effectiveness After Switching to Avalglucosidase Alfa in Late-Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study.

|Feb 28, 2026
Increased intervals in enzyme replacement therapy for stable type 1 Gaucher disease: A non-inferiority sequential trial emulation.

Maxime Beydon, Jérôme Stirnemann, Karima Yousfi

|Oct 27, 2025
Causes of Death and Comorbidities in Adult Patients With Late-Onset Pompe Disease: A French Pompe Registry Retrospective Study.

Diana Maria Chitimus, Céline Tard, Maxime Fournier

|Aug 01, 2025
Evaluating a predictive model of tyrosine kinase inhibitor therapy failure in a European-type cohort: a step towards population-specific tools.

Sylvain Moinard, Benjamin Lebecque, Tom Lachaise

|Jul 07, 2023
Characteristics of Patients With Late-Onset Pompe Disease in France: Insights From the French Pompe Registry in 2022.

Claire Lefeuvre, Marie De Antonio, Francoise Bouhour

|Dec 10, 2021
CRB1-Related Retinal Dystrophies in a Cohort of 50 Patients: A Reappraisal in the Light of Specific Müller Cell and Photoreceptor CRB1 Isoforms.

Kévin Mairot, Vasily Smirnov, Béatrice Bocquet

Pageof 2

Frequent Collaborators

3 joint publications

Sharam Attarian

2 joint publications

Yann Nguyen

2 joint publications

Pascal Laforêt

2 joint publications

Armelle Magot